{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:49:54Z","timestamp":1790614194719,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":3181,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1074\/jbc.m111.268797","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T01:49:24Z","timestamp":1323136164000},"page":"2099-2106","source":"Crossref","is-referenced-by-count":48,"title":["V2 Vasopressin Receptor (V2R) Mutations in Partial Nephrogenic Diabetes Insipidus Highlight Protean Agonism of V2R Antagonists"],"prefix":"10.1016","volume":"287","author":[{"given":"Kazuhiro","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Makita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Manaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Hisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Akioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Takubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norishi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taroh","family":"Iiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M111.268797_bib1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.pharmthera.2006.02.008","article-title":"Inactivating mutations of G protein-coupled receptors and diseases. Structure-function insights and therapeutic implications","volume":"111","author":"Tao","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1074\/jbc.M111.268797_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.med.55.091902.103843","article-title":"Inherited diseases involving G proteins and G protein-coupled receptors","volume":"55","author":"Spiegel","year":"2004","journal-title":"Annu .Rev. Med."},{"key":"10.1074\/jbc.M111.268797_bib3","doi-asserted-by":"crossref","first-page":"F257","DOI":"10.1152\/ajprenal.00491.2005","article-title":"Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus","volume":"291","author":"Robben","year":"2006","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1074\/jbc.M111.268797_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.ackd.2006.01.006","article-title":"Nephrogenic diabetes insipidus","volume":"13","author":"Bichet","year":"2006","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1074\/jbc.M111.268797_bib5","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1681\/ASN.V9101861","article-title":"Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus. Molecular basis of a mild clinical phenotype","volume":"9","author":"Ala","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1074\/jbc.M111.268797_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s100380200002","article-title":"Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients","volume":"47","author":"Chen","year":"2002","journal-title":"J. Hum. Genet."},{"key":"10.1074\/jbc.M111.268797_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2265.2007.03054.x","volume":"68","author":"Faerch","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"10.1074\/jbc.M111.268797_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/jcem.86.1.7165","article-title":"The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus","volume":"86","author":"Inaba","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1074\/jbc.M111.268797_bib9","first-page":"1703","article-title":"Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families","volume":"85","author":"Pasel","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1074\/jbc.M111.268797_bib10","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1210\/mend.11.12.0017","article-title":"Biochemical basis of partial nephrogenic diabetes insipidus phenotypes","volume":"11","author":"Sadeghi","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1074\/jbc.M111.268797_bib11","doi-asserted-by":"crossref","first-page":"F1518","DOI":"10.1152\/ajprenal.00331.2009","article-title":"Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus","volume":"297","author":"Faerch","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1074\/jbc.M111.268797_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/edrv.21.1.0390","article-title":"Uncovering molecular mechanisms involved in activation of G protein-coupled receptors","volume":"21","author":"Gether","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1074\/jbc.M111.268797_bib13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1124\/mol.107.040352","article-title":"Functional selectivity through protean and biased agonism. Who steers the ship?","volume":"72","author":"Kenakin","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1074\/jbc.M111.268797_bib14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tips.2007.06.004","article-title":"Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology","volume":"28","author":"Leach","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1074\/jbc.M111.268797_bib15","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1038\/sj.bjp.0706455","article-title":"G-protein-coupled receptors. Past, present and future","volume":"147","author":"Hill","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1074\/jbc.M111.268797_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1074\/jbc.M111.268797_bib17","doi-asserted-by":"crossref","first-page":"11406","DOI":"10.1073\/pnas.1936664100","article-title":"\u03b2-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors","volume":"100","author":"Azzi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.268797_bib18","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1073\/pnas.0701290104","article-title":"An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations","volume":"104","author":"Makita","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.268797_bib19","author":"Makita","year":"2008","journal-title":"AfCS Nature Molecule Pages"},{"key":"10.1074\/jbc.M111.268797_bib20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1096\/fj.00-0438rev","article-title":"Inverse, protean, and ligand-selective agonism: matters of receptor conformation","volume":"15","author":"Kenakin","year":"2001","journal-title":"FASEB J."},{"key":"10.1074\/jbc.M111.268797_bib21","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1172\/JCI116698","article-title":"X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis","volume":"92","author":"Bichet","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1074\/jbc.M111.268797_bib22","first-page":"278","article-title":"Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus","volume":"55","author":"Bichet","year":"1994","journal-title":"Am. J. Hum. Genet."},{"key":"10.1074\/jbc.M111.268797_bib23","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1681\/ASN.V1161044","article-title":"Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus","volume":"11","author":"Arthus","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1074\/jbc.M111.268797_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/gte.2006.10.157","article-title":"Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients","volume":"10","author":"Boson","year":"2006","journal-title":"Genet. Test."},{"key":"10.1074\/jbc.M111.268797_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.gim.0000223554.46981.7a","article-title":"Novel mutations underlying nephrogenic diabetes insipidus in Arab families","volume":"8","author":"Carroll","year":"2006","journal-title":"Genet. Med."},{"key":"10.1074\/jbc.M111.268797_bib26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/ajkd.2002.31993","article-title":"Intrafamilial phenotype variability in nephrogenic diabetes insipidus","volume":"39","author":"Kalenga","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1074\/jbc.M111.268797_bib27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F","article-title":"V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms","volume":"12","author":"Schoneberg","year":"1998","journal-title":"Hum. Mutat."},{"key":"10.1074\/jbc.M111.268797_bib28","doi-asserted-by":"crossref","first-page":"S278","DOI":"10.1002\/humu.1380110188","volume":"1","author":"Shoji","year":"1998","journal-title":"Hum. Mutat."},{"key":"10.1074\/jbc.M111.268797_bib29","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1056\/NEJMoa042743","article-title":"Nephrogenic syndrome of inappropriate antidiuresis","volume":"352","author":"Feldman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1074\/jbc.M111.268797_bib30","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/jpet.105.095554","article-title":"Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor","volume":"316","author":"Macion-Dazard","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1074\/jbc.M111.268797_bib31","doi-asserted-by":"crossref","first-page":"F253","DOI":"10.1152\/ajprenal.00247.2006","article-title":"Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones. Relevance to therapy of nephrogenic diabetes insipidus","volume":"292","author":"Robben","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1074\/jbc.M111.268797_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/371164a0","article-title":"Rapid GDP release from Gs \u03b1 in patients with gain and loss of endocrine function","volume":"371","author":"Iiri","year":"1994","journal-title":"Nature"},{"key":"10.1074\/jbc.M111.268797_bib33","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1073\/pnas.94.11.5656","article-title":"Conditional activation defect of a human Gs \u03b1 mutant","volume":"94","author":"Iiri","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.268797_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1073\/pnas.96.2.499","article-title":"A Gs \u03b1 mutant designed to inhibit receptor signaling through Gs","volume":"96","author":"Iiri","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.268797_bib35","doi-asserted-by":"crossref","first-page":"17424","DOI":"10.1073\/pnas.0708561104","article-title":"Human G(s\u03b1) mutant causes pseudohypoparathyroidism type Ia\/neonatal diarrhea, a potential cell-specific role of the palmitoylation cycle","volume":"104","author":"Makita","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.268797_bib36","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/me.2004-0080","article-title":"Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059","volume":"18","author":"Bernier","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1074\/jbc.M111.268797_bib37","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1681\/ASN.2005080854","article-title":"Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus","volume":"17","author":"Bernier","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1074\/jbc.M111.268797_bib38","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/mol.109.061804","article-title":"Functional characterization of vasopressin type 2 receptor substitutions (R137H\/C\/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis. Implications for treatments","volume":"77","author":"Rochdi","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1074\/jbc.M111.268797_bib39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1172\/JCI10254","article-title":"Dynamin is involved in human epithelial cell vacuolation caused by the Helicobacter pylori-produced cytotoxin VacA","volume":"107","author":"Suzuki","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1074\/jbc.M111.268797_bib40","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1091\/mbc.e02-05-0308","article-title":"Dynamin participates in focal extracellular matrix degradation by invasive cells","volume":"14","author":"Baldassarre","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1074\/jbc.M111.268797_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1073\/pnas.98.1.93","article-title":"Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus","volume":"98","author":"Barak","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.268797_bib42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.physiol.63.1.607","article-title":"Nephrogenic diabetes insipidus","volume":"63","author":"Morello","year":"2001","journal-title":"Annu. Rev. Physiol."},{"key":"10.1074\/jbc.M111.268797_bib43","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1210\/me.2008-0321","article-title":"Agonist-independent interactions between beta-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis","volume":"23","author":"Kocan","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1074\/jbc.M111.268797_bib44","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1124\/mol.107.034926","article-title":"Missing links. Mechanisms of protean agonism","volume":"71","author":"Neubig","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1074\/jbc.M111.268797_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10741-008-9109-7","article-title":"Hyponatremia in heart failure","volume":"14","author":"Farmakis","year":"2009","journal-title":"Heart Fail. Rev."},{"key":"10.1074\/jbc.M111.268797_bib46","first-page":"57","article-title":"Tolvaptan, hyponatremia, and heart failure","volume":"4","author":"Zmily","year":"2011","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"10.1074\/jbc.M111.268797_bib47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ki.2011.119","volume":"80","author":"Irazabal","year":"2011","journal-title":"Kidney Int."},{"key":"10.1074\/jbc.M111.268797_bib48","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1053\/j.ajkd.2010.11.029","article-title":"Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3\u20134 Study","volume":"57","author":"Torres","year":"2011","journal-title":"Am. J. Kidney Dis."},{"key":"10.1074\/jbc.M111.268797_bib49","doi-asserted-by":"crossref","first-page":"e8383","DOI":"10.1371\/journal.pone.0008383","article-title":"The constitutively active V2 receptor mutants conferring NSIAD are weakly sensitive to agonist and antagonist regulation","volume":"4","author":"Tenenbaum","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M111.268797_bib50","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1681\/ASN.2008121289","article-title":"Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus","volume":"20","author":"Jean-Alphonse","year":"2009","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820533036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820533036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M111.268797","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:19:40Z","timestamp":1641341980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820533036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0021925820533036"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m111.268797","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}